Guangdong Marubi Biotechnology Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Guangdong Marubi Biotechnology has a total shareholder equity of CN¥3.4B and total debt of CN¥250.9M, which brings its debt-to-equity ratio to 7.3%. Its total assets and total liabilities are CN¥4.4B and CN¥991.3M respectively. Guangdong Marubi Biotechnology's EBIT is CN¥264.8M making its interest coverage ratio -4.6. It has cash and short-term investments of CN¥2.1B.
Anahtar bilgiler
7.3%
Borç/özkaynak oranı
CN¥250.91m
Borç
Faiz karşılama oranı | -4.6x |
Nakit | CN¥2.10b |
Eşitlik | CN¥3.44b |
Toplam yükümlülükler | CN¥991.30m |
Toplam varlıklar | CN¥4.44b |
Son finansal sağlık güncellemeleri
Recent updates
Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher
Sep 26Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations
Aug 30Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital
Jun 19Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet
May 29Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?
May 07Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion
Mar 27Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around
Feb 29Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 603983's short term assets (CN¥2.6B) exceed its short term liabilities (CN¥969.6M).
Uzun Vadeli Yükümlülükler: 603983's short term assets (CN¥2.6B) exceed its long term liabilities (CN¥21.7M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 603983 has more cash than its total debt.
Borcun Azaltılması: 603983's debt to equity ratio has increased from 0% to 7.3% over the past 5 years.
Borç Kapsamı: 603983's debt is well covered by operating cash flow (134.9%).
Faiz Kapsamı: 603983 earns more interest than it pays, so coverage of interest payments is not a concern.